Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07216326 · ClinicalTrials.gov registry record · NA

Our Voices Matter: Intervention for Depression in Youth

A NA study of Metabolic Syndrome and Depressive Symptoms, sponsored by Ann & Robert H Lurie Children's Hospital of Chicago.

Recruiting
Registry status
NA
Development phase
300
Enrollment target
1
Study location

NCT07216326 is a NA study of Metabolic Syndrome and Depressive Symptoms that is actively recruiting participants, run by Ann & Robert H Lurie Children's Hospital of Chicago. The registered enrollment target is 300 participants, below the 1,202-participant average among 102 other Metabolic Syndrome trials with a reported enrollment target (75% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07216326, a NA study of Metabolic Syndrome and Depressive Symptoms, is actively recruiting participants, sponsored by Ann & Robert H Lurie Children's Hospital of Chicago.

RECRUITING
Registry status
NA
Development phase
300 participants
Enrollment target
1
Study location

Study Summary

Over 15 million people participated in racial justice protests nationwide during 2020-2021 spotlighting activism as a collective tool against structural racism and discrimination (SRD). SRD manifests as policies and practices (e.g., redlining, voter suppression, mass incarceration) that produce hostile environments that contribute to psychological distress, elevated allostatic load, and an elevated risk for chronic diseases and premature death, concentrated within Black and Latinx populations. While the connection between SRD and health is well documented, few studies provide evidence on strategies to reduce SRD and mitigate consequences on psychological and physiological outcomes. Thus, there is a critical need to rigorously test interventions that improve the mental and physical health of Black and Latinx populations, beginning in adolescence. The study's specific aims are to 1) Determine whether a racial justice activism behavioral intervention prevents and reduces depressive symptoms in Black and Latinx adolescents and young adults and 2) Determine whether a racial justice activism behavioral intervention lowers allostatic load scores in Black and Latinx adolescents and young adults. To accomplish these aims, the team will conduct a stage II group-based, multi-component, and multilevel randomized behavioral clinical trial. The investigators will collect psychological and physiological measures at baseline, then at defined intervals for 2 years post the racial justice activism intervention.

Interventions

  • BEHAVIORAL Racial Justice Activism Intervention ARM
  • BEHAVIORAL Adulting 101- Control Arm

Study Locations (1)

Illinois

  • Ann & Robert H. Lurie Children's Hospital of Chicago - Chicago

Trial Details

FieldValue
Enrollment Target 300 participants
Start Date 2025-06-06
Est. Completion 2028-12-29
Phase NA

What the Registry Record Tells You About NCT07216326

The ClinicalTrials.gov registry entry for NCT07216326 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 300 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,202-participant average among 102 other Metabolic Syndrome trials with a reported enrollment target (75% lower). The listed sponsor is Ann & Robert H Lurie Children's Hospital of Chicago, which has 159 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Metabolic Syndrome appearing as the primary indexed condition, and to 2 interventions - of which Racial Justice Activism Intervention ARM is the first listed.

NCT07216326 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.

Frequently Asked Questions

What is clinical trial NCT07216326 about?

NCT07216326 is a clinical study titled "Our Voices Matter: Intervention for Depression in Youth". Over 15 million people participated in racial justice protests nationwide during 2020-2021 spotlighting activism as a collective tool against structural racism and discrimination (SRD). SRD manifests as policies and practices (e.g., redlining, voter suppression, mass incarceration) that produce host...

What is the current status of trial NCT07216326?

This trial is currently recruiting. It is a NA study. The enrollment target is 300 participants. The study started on 2025-06-06. Estimated completion is 2028-12-29.

What conditions does trial NCT07216326 study?

This clinical trial studies the following conditions: Metabolic Syndrome, Depressive Symptoms, Allostatic Load.

What interventions are being tested in trial NCT07216326?

The interventions under investigation include: Racial Justice Activism Intervention ARM (BEHAVIORAL), Adulting 101- Control Arm (BEHAVIORAL).

Who is sponsoring clinical trial NCT07216326?

This trial is sponsored by Ann & Robert H Lurie Children's Hospital of Chicago, which has 159 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07216326 being conducted?

This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Metabolic Syndrome

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.